Expert Gives Lowdown On Adverse Event Reporting Bill For Monograph OTCs
• By Katia Fowler
The compliance of companies newly subject to adverse event reporting and record-keeping requirements will likely be evaluated by FDA on a "performance-oriented basis," said Rick Kingston, PharmD, president and senior clinical toxicologist at SafetyCall International, an adverse event call center
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
